Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct 9:18:1687-1703.
doi: 10.2147/CIA.S423122. eCollection 2023.

Management of Glucose-Lowering Therapy in Older Adults with Type 2 Diabetes: Challenges and Opportunities

Jean Doucet  1 , Pierre Gourdy  2   3 , Laurent Meyer  4 , Nabil Benabdelmoumene  5 , Isabelle Bourdel-Marchasson  6   7
Affiliations
Review

Management of Glucose-Lowering Therapy in Older Adults with Type 2 Diabetes: Challenges and Opportunities

Jean Doucet et al. Clin Interv Aging. .

Abstract

The population of older adults (≥65 years) with type 2 diabetes mellitus (T2DM) is diverse, encompassing individuals with varying functional capabilities, living arrangements, concomitant medical conditions, and life expectancies. Hence, their categorization into different patient profiles (ie, good health, intermediate health, poor health) may aid in clinical decision-making when establishing glycemic goals and pharmacological treatment strategies. Further granularity in assessing each patient profile through interdisciplinary collaboration may also add precision to therapeutic and monitoring decisions. In this review, we discuss with a multidisciplinary approach how to deliver the best benefit from advanced diabetes therapies and technologies to older adults with T2DM according to each patient profile. There remain however several areas that deserve further research in older adults with T2DM, including the efficacy and safety of continuous glucose monitoring and automated insulin delivery systems, the switch to once-weekly insulin, the effectiveness of multidisciplinary care models, and the use of supported telemedicine and remote blood glucose monitoring in the oldest-old (≥85 years) who particularly require the assistance of others.

Keywords: management; older adults; patient profiles; type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

Jean Doucet has received occasional fees, either personally or institutionally, for the activities of speaking or scientific advising from Novo Nordisk, Eli Lilly, and Boehringer Ingelheim. Pierre Gourdy has received occasional fees, either personally or institutionally, for the activities of speaking, scientific advising, or clinical research from Abbott, Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Gilead, GlaxoSmithKline, Merck Sharp & Dohme, Novo Nordisk, Organon, Pfizer, and Sanofi. Laurent Meyer has received occasional fees, either personally or institutionally, for the activities of speaking, scientific advising, or clinical research from Abbott, AstraZeneca, Boehringer Ingelheim, Dexcom, Eli Lilly, Novo Nordisk, Merck Sharp & Dohme, Pfizer, Servier, Medtronic, and Isis Diabète. Nabil Benabdelmoumene has received occasional fees, either personally or institutionally, from AstraZeneca, Novo Nordisk, Boehringer Ingelheim, and Eli Lilly. Isabelle Bourdel-Marchasson has received occasional fees from Novo-Nordisk for activities of speaking or scientific advising. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Challenges in the management of type 2 diabetes mellitus (T2DM) in older adults.
Figure 2
Figure 2
Hemoglobin A1c (HbA1c) goals according to patient profiles of older adults with type 2 diabetes.
Figure 3
Figure 3
Management algorithm of type 2 diabetes mellitus (T2DM) in older adults.
Figure 4
Figure 4
Glycemic monitoring in older adults with type 2 diabetes.
See this image and copyright information in PMC

References

    1. Orimo H, Ito H, Suzuki T, Araki A, Hosoi T, Sawabe M. Reviewing the definition of “elderly”. Geriatr Gerontol Int. 2006;6(3):149–158. doi:10.1111/j.1447-0594.2006.00341.x - DOI
    1. Singh S, Bajorek B. Defining ‘elderly’ in clinical practice guidelines for pharmacotherapy. Pharm Pract. 2014;12(4):489. doi:10.4321/s1886-36552014000400007 - DOI - PMC - PubMed
    1. Ouchi Y, Rakugi H, Arai H, et al. Redefining the elderly as aged 75 years and older: proposal from the joint committee of Japan gerontological Society and the Japan Geriatrics Society. Geriatr Gerontol Int. 2017;17(7):1045–1047. doi:10.1111/ggi.13118 - DOI - PubMed
    1. Lee SB, Oh JH, Park JH, Choi SP, Wee JH. Differences in youngest-old, middle-old, and oldest-old patients who visit the emergency department. Clin Exp Emerg Med. 2018;5(4):249–255. doi:10.15441/ceem.17.261 - DOI - PMC - PubMed
    1. ElSayed NA, Aleppo G, Aroda VR, et al. 13. Older adults: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S216–229. doi:10.2337/dc23-S013 - DOI - PMC - PubMed